Prolonged Carriage of Carbapenemase-Producing : Clinical Risk Factors and the Influence of Carbapenemase and Organism Types
Overview
Affiliations
Prolonged carriage of carbapenemase-producing (CPE) constitutes a substantial epidemiologic threat. This study aimed to evaluate whether the types of carbapenemase and organism can affect the duration of carriage and to evaluate the clinical factors associated with prolonged carriage. We retrospectively reviewed data for patients admitted between May 2013 and August 2018 who were identified as CPE carriers. A total of 702 patients were identified; the major types of carbapenemase and organism were Oxacillinase (OXA)-48-like ( = 480, 68.4%) and () ( = 584, 83.2%). The analyses of time to spontaneous decolonization using the Kaplan-Meier method showed that OXA-48-like and were significantly associated with prolonged carriage (log rank, = 0.001 and < 0.001). In multivariable logistic analysis to assess the risk factors for CPE prolonged carriage in the 188 patients with available follow-up culture data for 3 months, (adjusted odds ratio [aOR] 6.58; 95% confidence interval [CI], 1.05-41.27; = 0.044), CPE positive clinical specimen (aOR 11.14; 95% CI, 4.73-26.25; < 0.001), and concurrent infection (CDI) (aOR 3.98, 95% CI 1.29-12.26; = 0.016) were predictive of prolonged carriage. Our results suggest that CP- may have higher probability of prolonged carriage, while the effect of OXA-48-like CPE is inconclusive. Furthermore, patients with CP- who had positive clinical specimen or concurrent CDI can cause a vicious circle in prolonged carriage.
Kim M, Jeon K, Kym D, Jung J, Jang Y, Han S Antimicrob Resist Infect Control. 2025; 14(1):3.
PMID: 39881424 PMC: 11780852. DOI: 10.1186/s13756-025-01514-9.
Lade H, Jeong S, Jeon K, Kim H, Kim H, Song W Antibiotics (Basel). 2023; 12(7).
PMID: 37508311 PMC: 10376851. DOI: 10.3390/antibiotics12071215.
Chen X, Zhou M, Yan Q, Jian Z, Liu W, Li H J Clin Lab Anal. 2022; 36(11):e24715.
PMID: 36181301 PMC: 9701893. DOI: 10.1002/jcla.24715.
Sarowska J, Choroszy-Krol I, Jama-Kmiecik A, Maczynska B, Cholewa S, Frej-Madrzak M Pathogens. 2022; 11(8).
PMID: 36014980 PMC: 9416609. DOI: 10.3390/pathogens11080859.